Organ support & nutrition

Veno‐venous extracorporeal membrane oxygenation for severe COVID ‐19 associated acute respiratory distress syndrome: A retrospective, nationwide, Danish cohort study

Acta Anaesthesiol ScandPublished Retrospective cohort study

Authors' conclusion

A nationwide, Danish cohort study of 68 COVID-19 patients supported with V-V ECMO, showed a 90-day survival of 43%, which is in accordance with reports from comparable cohorts. Age of 60 years or more was associated with an increased risk of mortality. Pre-existing hypertension was associated with a decreased risk of mortality.

Study context

Population
Patients with COVID-19 associated ARDS supported with V–V ECMO in Denmark, March 10, 2020, to December 31, 2021cannulated for V–V ECMO
Participants
68 patients
Outcome
Mortality
Follow-up
90 days
Methodological detailsnationwide, 197 enquiries for ECMO; 118 considered eligible; 71 cannulated (3 V-A ECMO for right sided HF, 68 V-V ECMO); 2 accepted for V-V ECMO died during cannulation
  • Nationwide
  • 197 enquiries for ECMO; 118 considered eligible; 71 cannulated (3 V-A ECMO for right sided HF, 68 V-V ECMO); 2 accepted for V-V ECMO died during cannulation

Main finding

As reported in the abstract

90-day mortality

V-V ECMO

43%

Observational data: associations, not effects.

Further findings

Duration of ECMO support

Median duration of ECMO support
13 days (IQR 7-21)

Duration of mechanical ventilation

Median duration of mechanical ventilation
26 days (IQR 14-42)

ICU LOS

Median ICU stay
34 days (IQR 17-46)

Hospital LOS

Median length of hospital stay
41 days (IQR 25-56)

Risk factors for mortality (multivariate Cox regression)

Age ≥60 years associated with increased risk of mortality
Pre-existing hypertension associated with decreased risk of mortality

Original publication

Veno‐venous extracorporeal membrane oxygenation for severe COVID ‐19 associated acute respiratory distress syndrome: A retrospective, nationwide, Danish cohort study. Acta Anaesthesiol Scand. Published 22 October 2024. doi:10.1111/aas.14522

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.